CN Patent

CN114957259A — 氰基取代的芳香双环类化合物及其应用

Assigned to Medshine Discovery Inc · Expires 2022-08-30 · 4y expired

What this patent protects

新的氰基取代的芳香双环类化合物及其应用，具体公开了式(III)所示化合物及其药学上可接受的盐。

USPTO Abstract

新的氰基取代的芳香双环类化合物及其应用，具体公开了式(III)所示化合物及其药学上可接受的盐。

Drugs covered by this patent

taletrectinib-adipate (TALETRECTINIB ADIPATE)

Patent Metadata

Patent number: CN114957259A
Jurisdiction: CN
Classification: —
Expires: 2022-08-30
Drug substance claim: No
Drug product claim: No
Assignee: Medshine Discovery Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.